Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1

European Journal of Pediatrics

Volumn 159, Issue 10, 2000, Pages 778-782

  Hainaut, Marc ^a   Peltier, Cécile Alexandra ^a   Gérard, Michèle ^a   Marissens, Denise ^a   Zissis, Georges ^a   Levy, Jack ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antiretroviral therapy; HIV 1 infection; Paediatrics; Reverse transcriptase inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS INHIBITION; VIRUS LOAD; VIRUS TITRATION;

EID: 0033812412     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008346     Document Type: Article

References (16)

1. Proposed definitions for in utero versus intrapartum transmission of HIV-1
2. Early establishment of a pool of latently infected resting CD4+ T cells during primary HIV-1 infection
3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
4. Children born to women with HIV-1 infection: Natural history and risk of transmission
5. Age-related standards for T-lymphocyte subsets based on uninfected children born to HIV-1 infected women
6. Effects of a combination of zidovudine, didanosine and lamivudine on primary human immunodeficiency virus type 1 infection
7. DNA polymerase chain reaction for the diagnosis of vertical HIV infection
8. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection
9. Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants
10. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses
11. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
12. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model
13. Viral load and disease progression in infants infected with human immunodeficiency virus type 1
14. Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin
15. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-I) infection: Partial normalization of T lymphocytes subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia
16. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy